About
Infection protection for catheters & ports
Areas of Focus
Categories
Uncategorized Medical Device
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
0
As Collaborator
3
Total Enrollment
232
By Phase
NA: 1PHASE4: 1PHASE3: 1
By Status
COMPLETED: 2UNKNOWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT06660641Collaborator
Clinical Trial Comparing TaurolockTMHep100 (Taurolidine 1.35%) and 0.9% Saline As Prevention of Recurrent Catheter-related Bloodstream Infections
NACompleted
61 participants
Started: Jun 3, 2019 · Completed: Feb 28, 2022
NCT01948245Collaborator
Clinical Trial Comparing Catheter Lock Solutions TaurolockTMHep 100 and Heparin 100 IE/ml.
PHASE4Unknown
42 participants
Started: Oct 31, 2013 · Completed: Dec 31, 2016
NCT00735813Collaborator
Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia
PHASE3Completed
129 participants
Started: Apr 30, 2008 · Completed: Sep 30, 2012
Locations (1)
Headquarters
Waldbüttelbrunn, Germany
Map
Loading map...